The CD3+CD4+ lymphopenia led to a significantly lower CD4/CD8-ratio (0.9 ± 0.6 versus 2.1 ± 1.1, P<0.001) in DLBCL patients. This evidence concerns the gene CD8A and diffuse large B-cell lymphoma.